Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Seattle Genetics Initiates Pivotal Trial of SGN-35 for Hodgkin Lymphoma
Seattle Genetics Initiates Pivotal Trial of SGN-35 for Hodgkin Lymphoma
Seattle Genetics Initiates Pivotal Trial of SGN-35 for Hodgkin Lymphoma
Submitted by
admin
on February 19, 2009 - 9:52am
Source:
Yahoo
News Tags:
Seattle Genetics
drug trials
Hodgkin's lymphoma
Headline:
Seattle Genetics Initiates Pivotal Trial of SGN-35 for Hodgkin Lymphoma
Do Not Allow Advertisers to Use My Personal information
